98%
921
2 minutes
20
Unlike somatic cells, sperm have several-fold more available-thiols that are susceptible to redox-active agents. The present study explains the mechanism behind the instant sperm-immobilizing and trichomonacidal activities of pyrrolidinium pyrrolidine-1-carbodithioate (PPC), a novel thiol agent rationally created for prophylactic contraception by minor chemical modifications of some known thiol drugs. PPC, and its three derivatives (with potential active-site blocked by alkylation), were synthesized and evaluated against live human sperm and metronidazole-susceptible and resistant Trichomonas vaginalis, in vitro. Sperm hexokinase activity was evaluated by coupled enzyme assay. PPC irreversibly immobilized 100% human sperm in ∼30 seconds and totally eliminated Trichomonas vaginalis more efficiently than nonoxynol-9 and metronidazole. It significantly inhibited (P<0.001) thiol-sensitive sperm hexokinase. However, the molecule completely lost all its biological activities once its thiol group was blocked by alkylation. PPC was subsequently formulated into a mucoadhesive vaginal film using GRaS excipients and evaluated for spermicidal and microbicidal activities (in vitro), and contraceptive efficacy in rabbits. PPC remained fully active in quick-dissolving, mucoadhesive vaginal-film formulation, and these PPC-films significantly reduced pregnancy and fertility rates in rabbits. The films released ∼90% of PPC in simulated vaginal fluid (pH 4.2) at 37°C in 5 minutes, in vitro. We have thus discovered a common target (reactive thiols) on chiefly-anaerobic, redox-sensitive cells like sperm and Trichomonas, which is susceptible to designed chemical interference for prophylactic contraception. The active thiol in PPC inactivates sperm and Trichomonas via interference with crucial sulfhydryl-disulfide based reactions, e.g. hexokinase activation in human sperm. In comparison to non-specific surfactant action of OTC spermicide nonoxynol-9, the action of thiol-active PPC is apparently much more specific, potent and safe. PPC presents a proof-of-concept for prophylactic contraception via manipulation of thiols in vagina for selective targeting of sperm and Trichomonas, and qualifies as a promising lead for the development of dually protective vaginal-contraceptive.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694959 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0067365 | PLOS |
Med Sci (Paris)
September 2025
Service de Gynécologie-Obstétrique, Hôpital Pitié-Salpêtrière, DMU ORIGYNE Femmes-Mères-Enfants, APHP, Paris, France - Sorbonne Université, Faculté de Santé, Paris, France.
The internal condom (commonly referred to as the female condom), which can be used by both men and women, is a single-use medical device that can be inserted several hours before sexual intercourse for the prevention of sexually transmitted infections (STIs) and for contraception. This review presents an overview of its use, and a summary of the technical and regulatory aspects. We will see that this device is almost as effective as its external counterpart and offers better protection against STIs, but that it remains very underused in the general population.
View Article and Find Full Text PDFIndian J Public Health
September 2025
Former Director, ICMR-National Institute for Research in Bacterial Infections (NIRBI), Kolkata, West Bengal, India.
Background: Female sex workers (FSWs) constitute a significant portion of high-risk groups (HRGs) in the districts of West Bengal, as indicated by HRG size mapping exercises.
Objectives: This study aimed to evaluate the knowledge of HIV/AIDS and condom usage practices among FSWs in clusters selected from districts in West Bengal for behavioural surveillance surveys (BSS)-lite.
Materials And Methods: BSS-lite was implemented in designated districts of West Bengal and interviews with 399 brothel and street-based FSWs from January to March 2020 were conducted utilizing computer-assisted personal interview or audio-computer assisted self-interview.
BMC Public Health
September 2025
Stigma and Resilience Among Vulnerable Youth Centre, The University of British Columbia, University of British Columbia School of Nursing, T201-2211 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada.
Background: Migrant youth in Canada are disproportionately vulnerable to the consequences of inadequate contraception use compared to their Canada-born peers, yet the sexual health behaviours of this population across time are poorly understood. This study mapped national Canadian trends in migrant adolescent sexual health behaviors disaggregated by migrant status and sex over eight years.
Methods: Canadian Health Behaviour in School-aged Children (HBSC) study data were analyzed in 2014, 2018, and 2022 for sexual experience, condom, contraceptive pill, dual and neither method use at last intercourse.
Gates Open Res
September 2025
School of Public Health, Imperial College London, London, England, W2 1PG, UK.
Background: Gender norms against adolescent girls and young women (AGYW)'s having pre-marital sex and using condoms in marriage are included as barriers to motivation to use condoms in HIV prevention cascades. Representative data on gender norms are needed to test this assumption.
Methods: General-population survey participants in Manicaland, Zimbabwe (ages≥15, N=9803) reported agreement/disagreement with statements on gender norms.
Vulnerable Child Youth Stud
January 2025
Duke Global Health Institute, Duke Univeristy, Durham, North Carolina, United States of America.
Adolescent girls and young women are disproportionately affected by HIV in many lower-resource settings. These individuals are often excluded from early clinical trials for new HIV prevention products, thus delaying potential access. We explored adolescent girls' and young women's (AGYW) perceptions of HIV risk, perspectives on trial participation, and understanding of research concepts.
View Article and Find Full Text PDF